Status:
COMPLETED
Spinal Cord Injury - Exercise
Lead Sponsor:
HealthPartners Institute
Conditions:
Spinal Cord Injuries
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Long lasting inflammation in the body is related to cardiovascular and respiratory disease, which are the two most common causes of death in people living with spinal cord injury (SCI). Individuals wi...
Eligibility Criteria
Inclusion
- Ability to provide and provision of signed and dated informed consent form
- Age 18-70
- Diagnosis of SCI and post injury ≥ 6 months
- Able to achieve adequate active range of motion at the elbow and wrist (flexion/extension) and able to achieve at least 90° active shoulder flexion, in order to complete study activities
Exclusion
- Non-English speaking
- Exercise program participation ≤1 month from study enrollment or any other exercise participation during the duration of the study
- Patients with significant cognitive impairment of any etiology that prevents them from being able to participate
- Patients that were given sternal or spinal precautions that would prevent excessive twisting, bending, overhead reaching and lifting over 10 pounds
- Patients with a history heart failure, chronic lung disease, angina or any other condition that causes unreasonable shortness of breath on exertion
- Has been diagnosed with autonomic dysreflexia that is severe, unstable, and uncontrolled
- Requires ventilator support
- Spasms that limit the ability of the subjects to participate in the study training as determined by the Investigator
- Pregnant, planning to become pregnant
- Any other medical conditions that could affect their ability to participate in the exercise program (as determined by study investigators)
- Active participation or past participation ≤3 months in any other interventional study.
- Unwilling to participate in all study related activities
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2024
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05376449
Start Date
May 9 2022
End Date
September 13 2024
Last Update
October 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HealthPartners Neuroscience Center
Saint Paul, Minnesota, United States, 55130